Viewing Study NCT01028092


Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-02-06 @ 1:33 AM
Study NCT ID: NCT01028092
Status: COMPLETED
Last Update Posted: 2014-07-08
First Post: 2009-12-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
Sponsor: University Hospital, Brest
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: EVEROLD
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None OTHER_GOV View